Impaired Proteasome Function in Alzheimer's Disease

Jeffrey N. Keller, Keith B. Hanni, William R. Markesbery

Journal of Neurochemistry · 2000 · 840 citations · 19 references

Concepts

TL;DR

Inhibition of proteasome activity can cause neuron degeneration, yet its alteration in neurodegenerative disease had not been demonstrated. The study measured proteasome activity in post‑mortem brains from 16 Alzheimer’s disease patients and nine matched controls. AD brains exhibited markedly reduced proteasome activity in hippocampus, parahippocampal, temporal, and parietal regions (28–48%) but not in occipital or cerebellum, and this reduction was not due to lower proteasome expression, suggesting post‑translational inhibition may contribute to Alzheimer’s‑related neurodegeneration.

Abstract

Abstract : Inhibition of proteasome activity is sufficient to induce neuron degeneration and death ; however, altered proteasome activity in a neurodegenerative disorder has not been demonstrated. In the present study, we analyzed proteasome activity in short‐postmortem‐interval autopsied brains from 16 Alzheimer's disease (AD) and nine age‐ and sex‐matched controls. A significant decrease in proteasome activity was observed in the hippocampus and parahippocampal gyrus (48%), superior and middle temporal gyri (38%), and inferior parietal lobule (28%) of AD patients compared with controls. In contrast, no significant decrease in proteasome activity was observed in either the occipital lobe or the cerebellum. The loss of proteasome activity was not associated with a decrease in proteasome expression, suggesting that the proteasome may become inhibited in AD by a posttranslational modification. Together, these data indicate a possible role for proteasome inhibition in the neurodegeneration associated with AD.

References

19